首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Development of immunoaffinity solid phase microextraction probes for analysis of sub ng/mL concentrations of 7-aminoflunitrazepam in urine.
【24h】

Development of immunoaffinity solid phase microextraction probes for analysis of sub ng/mL concentrations of 7-aminoflunitrazepam in urine.

机译:开发用于分析尿液中亚ng / mL浓度低于ng / mL的免疫亲和固相微萃取探针。

获取原文
获取原文并翻译 | 示例
           

摘要

We report on the development of solid phase microextraction probes for drug analysis, prepared with antibodies specific for benzodiazepines covalently immobilized to the surface. In the technique, immobilized antibody probes are exposed to a sample containing the drug for 30 min. Extracted drugs are subsequently desorbed from the probes in 500 microL of methanolic desorption solution, which is dried, reconstituted in a small volume of injection solution and analysed by LC-MS/MS. The antibodies were characterized both before and after immobilization, to facilitate the rational selection of antibodies for such analyses. Polyclonal and monoclonal antibodies were compared as was the impact of affinity purification of the polyclonal antibody to isolate the drug-specific fraction. The probes were evaluated for utility in analyzing 7-aminoflunitrazepam at sub ng/mL concentrations in urine, which is expected to be found several days after a single oral dose of 2 mg of flunitrazepam. Such analyses are required in monitoring for abuse of this drug, both in terms of 'club drug' use and in cases of drug-facilitated sexual assault. In these cases drug concentrations in blood and urine are much lower than in chronic abuse cases and are difficult to analyse by conventional methods. The method developed has a limit of detection of 0.02 ng/mL, with accuracy ranging from 1% to 27% and precision (% R.S.D.) ranging from 2% to 10% between the lower and upper limits of quantitation for the analysis of 7-aminoflunitrazepam in urine. The dynamic range of the method is from 0.02 ng/mL, which is limited by the instrument sensitivity, to 0.5 ng/mL, which is approaching the capacity of the probes. This would allow for quantitative analysis of samples at concentrations below that measurable by many other methods for general benzodiazepines analysis from urine, and a highly selective screen for samples at higher concentrations. The method has similar limits of detection to the most sensitive literature methods specifically designed forsuch analysis but with the advantage of significantly simplified sample preparation. This simplification makes the technique more amenable for use by both professionals and non-professionals.
机译:我们报告了用于药物分析的固相微萃取探针的发展,该探针是用共价固定在表面的苯二氮杂类特异性抗体制备的。在该技术中,将固定的抗体探针暴露于含有药物的样品中30分钟。随后将提取的药物从探针中解吸到500微升甲醇解吸溶液中,将其干燥,在少量注射溶液中重建,并通过LC-MS / MS进行分析。在固定之前和之后都对抗体进行了表征,以便于合理选择抗体进行此类分析。比较了多克隆抗体和单克隆抗体,以及亲和纯化多克隆抗体以分离药物特异性级分的影响。评估了这些探针在尿液中亚ng / mL浓度下分析7-氨基氟硝西m的效用,预计单次口服2 mg氟硝西epa后数日即可发现。无论是在“俱乐部毒品”的使用方面,还是在毒品促成的性侵犯案件中,都需要进行此类分析以监测这种药物的滥用情况。在这些情况下,血液和尿液中的药物浓度远低于慢性滥用情况,因此很难通过常规方法进行分析。所开发的方法的定量下限和上限之间的检出限为0.02 ng / mL,准确度范围为1%至27%,精度(%RSD)范围为2%至10%。尿液中的氨氟硝西epa。该方法的动态范围从0.02 ng / mL(受仪器灵敏度限制)到0.5 ng / mL(接近探针的容量)。这将允许对浓度低于可通过许多其他方法从尿液中进行一般苯并二氮杂卓分析的方法进行定量分析,并对高浓度样品进行高度选择性的筛选。该方法的检测极限与专为此类分析而设计的最敏感文献方法相似,但具有大大简化样品制备的优点。这种简化使该技术更适合专业人士和非专业人士使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号